Nobivac Respira Bb vet. suspension for injection for dogs
Nobivac Respira Bb vet. suspension for injection for dogs
Not authorised
- Bordetella bronchiseptica, strain Bb7 92932, fimbriae
Product identification
Medicine name:
Nobivac Respira Bb vet. suspension for injection for dogs
Active substance:
- Bordetella bronchiseptica, strain Bb7 92932, fimbriae
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Bordetella bronchiseptica, strain Bb7 92932, fimbriae88.00/enzyme-linked immunosorbent assay unit1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AB03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Cyprus
Package description:
- Available only in Danish
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
- CY00825V
Date of authorisation status change:
Reference member state:
-
Denmark
Procedure number:
- DK/V/0123/002
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 29/05/2023
PI.pdf
English (PDF)
Download Published on: 27/01/2022